4521 Stock Overview
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Kaken Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,438.00 |
| 52 Week High | JP¥4,577.00 |
| 52 Week Low | JP¥3,161.00 |
| Beta | 0.25 |
| 11 Month Change | 14.83% |
| 3 Month Change | 7.90% |
| 1 Year Change | 34.53% |
| 33 Year Change | 5.92% |
| 5 Year Change | -24.52% |
| Change since IPO | 84.92% |
Recent News & Updates
Estimating The Intrinsic Value Of Kaken Pharmaceutical Co., Ltd. (TSE:4521)
Aug 13
Kaken Pharmaceutical's (TSE:4521) Dividend Will Be ¥75.00
Jul 26Shareholder Returns
| 4521 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.4% | -4.5% | -0.4% |
| 1Y | 34.5% | 8.6% | 11.4% |
Return vs Industry: 4521 exceeded the JP Pharmaceuticals industry which returned 8.6% over the past year.
Return vs Market: 4521 exceeded the JP Market which returned 11.4% over the past year.
Price Volatility
| 4521 volatility | |
|---|---|
| 4521 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4521 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4521's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1917 | 1,135 | Hiroyuki Horiuchi | www.kaken.co.jp |
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. The company offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Fiblast, a wound-healing agent; Ecclock for the treatment of primary axillary hyperhidrosis; Regroth, a periodontal regenerative agent; Hernicore for the treatment of lumbar disc herniation; and Seprafilm, an adhesion barrier used primarily in surgery and gynecology to reduce complications from post-operative adhesions. It also provides agrochemicals and animal health products, including Polyoxins that is used as fungicide; Pentoxazone and Metamifop rice herbicides; and Salinomycin, an anti-coccidial feed additive for chickens.
Kaken Pharmaceutical Co., Ltd. Fundamentals Summary
| 4521 fundamental statistics | |
|---|---|
| Market cap | JP¥168.07b |
| Earnings (TTM) | JP¥18.24b |
| Revenue (TTM) | JP¥87.25b |
9.2x
P/E Ratio1.9x
P/S RatioIs 4521 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4521 income statement (TTM) | |
|---|---|
| Revenue | JP¥87.25b |
| Cost of Revenue | JP¥34.32b |
| Gross Profit | JP¥52.92b |
| Other Expenses | JP¥34.68b |
| Earnings | JP¥18.24b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 481.73 |
| Gross Margin | 60.66% |
| Net Profit Margin | 20.91% |
| Debt/Equity Ratio | 2.5% |
How did 4521 perform over the long term?
See historical performance and comparisonDividends
3.4%
Current Dividend Yield16%
Payout RatioDoes 4521 pay a reliable dividends?
See 4521 dividend history and benchmarks| Kaken Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Nov 29 2024 |
| Days until Ex dividend | 56 days |
| Days until Dividend pay date | 7 days |
Does 4521 pay a reliable dividends?
See 4521 dividend history and benchmarks